In PC tissue, high-level LC3B expression is associated with key clinicopathological indicators of aggressive disease, including high Gleason scores and advanced tumor grades, highlighting its involvement in tumor progression and aggressive growth [19]. Here, MAP1LC3B is linked to neoplasm.